Cubist Systematic Strategies’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,661
| Closed | -$5.09M | – | 1482 |
|
|
2024
Q1 | $5.09M | Buy |
33,661
+14,770
| +78% | +$2.23M | 0.03% | 504 |
|
|
2023
Q4 | $2.38M | Buy |
+18,891
| New | +$2.38M | 0.02% | 751 |
|
|
2023
Q1 | – | Sell |
-9,603
| Closed | -$1.17M | – | 2828 |
|
|
2022
Q4 | $1.17M | Sell |
9,603
-2,521
| -21% | -$308K | 0.01% | 1637 |
|
|
2022
Q3 | $1.25M | Buy |
12,124
+9,526
| +367% | +$984K | 0.01% | 1904 |
|
|
2022
Q2 | $242K | Buy |
+2,598
| New | +$242K | ﹤0.01% | 3052 |
|
|
2022
Q1 | – | Sell |
-110
| Closed | -$15K | – | 3524 |
|
|
2021
Q4 | $15K | Sell |
110
-28
| -20% | -$3.82K | ﹤0.01% | 3390 |
|
|
2021
Q3 | $22K | Sell |
138
-508
| -79% | -$81K | ﹤0.01% | 2882 |
|
|
2021
Q2 | $85K | Buy |
646
+355
| +122% | +$46.7K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $38K | Sell |
291
-590
| -67% | -$77K | ﹤0.01% | 2747 |
|
|
2020
Q4 | $147K | Buy |
+881
| New | +$147K | ﹤0.01% | 2341 |
|
|
2020
Q2 | – | Sell |
-92
| Closed | -$10K | – | 2387 |
|
|
2020
Q1 | $10K | Buy |
+92
| New | +$10K | ﹤0.01% | 2087 |
|
|
2019
Q2 | – | Sell |
-8,517
| Closed | -$1M | – | 2439 |
|
|
2019
Q1 | $1M | Buy |
8,517
+3,995
| +88% | +$470K | 0.03% | 764 |
|
|
2018
Q4 | $283K | Buy |
+4,522
| New | +$283K | 0.01% | 1322 |
|